File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: COVID-19 as a catalyst for reimagining cervical cancer prevention

TitleCOVID-19 as a catalyst for reimagining cervical cancer prevention
Authors
Issue Date18-Apr-2023
PublishereLife Sciences Publications
Citation
eLife, 2023, v. 12 How to Cite?
Abstract

Cervical cancer has killed millions of women over the past decade. In 2019 the World Health Organization launched the Cervical Cancer Elimination Strategy, which included ambitious targets for vaccination, screening, and treatment. The COVID-19 pandemic disrupted progress on the strategy, but lessons learned during the pandemic – especially in vaccination, self-administered testing, and coordinated mobilization on a global scale – may help with efforts to achieve its targets. However, we must also learn from the failure of the COVID-19 response to include adequate representation of global voices. Efforts to eliminate cervical cancer will only succeed if those countries most affected are involved from the very start of planning. In this article we summarize innovations and highlight missed opportunities in the COVID response, and make recommendations to leverage the COVID experience to accelerate the elimination of cervical cancer globally.


Persistent Identifierhttp://hdl.handle.net/10722/329071
ISSN
2023 Impact Factor: 6.4
2023 SCImago Journal Rankings: 3.932
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLuckett, R-
dc.contributor.authorFeldman, S-
dc.contributor.authorWoo, YL-
dc.contributor.authorMoscicki, AB-
dc.contributor.authorGiuliano, AR-
dc.contributor.authorde Sanjose, S-
dc.contributor.authorKaufmann, AM-
dc.contributor.authorLeung, SOA-
dc.contributor.authorGarcia, F-
dc.contributor.authorChan, K-
dc.contributor.authorBhatla, N-
dc.contributor.authorStanley, M-
dc.contributor.authorBrotherton, J-
dc.contributor.authorPalefsky, J-
dc.contributor.authorGarland, S -
dc.date.accessioned2023-08-05T07:55:04Z-
dc.date.available2023-08-05T07:55:04Z-
dc.date.issued2023-04-18-
dc.identifier.citationeLife, 2023, v. 12-
dc.identifier.issn2050-084X-
dc.identifier.urihttp://hdl.handle.net/10722/329071-
dc.description.abstract<p>Cervical cancer has killed millions of women over the past decade. In 2019 the World Health Organization launched the Cervical Cancer Elimination Strategy, which included ambitious targets for vaccination, screening, and treatment. The COVID-19 pandemic disrupted progress on the strategy, but lessons learned during the pandemic – especially in vaccination, self-administered testing, and coordinated mobilization on a global scale – may help with efforts to achieve its targets. However, we must also learn from the failure of the COVID-19 response to include adequate representation of global voices. Efforts to eliminate cervical cancer will only succeed if those countries most affected are involved from the very start of planning. In this article we summarize innovations and highlight missed opportunities in the COVID response, and make recommendations to leverage the COVID experience to accelerate the elimination of cervical cancer globally.</p>-
dc.languageeng-
dc.publishereLife Sciences Publications-
dc.relation.ispartofeLife-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleCOVID-19 as a catalyst for reimagining cervical cancer prevention-
dc.typeArticle-
dc.identifier.doi10.7554/eLife.86266-
dc.identifier.scopuseid_2-s2.0-85159541770-
dc.identifier.volume12-
dc.identifier.eissn2050-084X-
dc.identifier.isiWOS:000986671700001-
dc.identifier.issnl2050-084X-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats